20-HETE synthesis inhibition promotes cerebral protection after intracerebral hemorrhage without inhibiting angiogenesis

Xiaoning Han, Xiaochun Zhao, Xi Lan, Qian Li, Yufeng Gao, Xi Liu, Jieru Wan, Zeng Jin Yang, Xuemei Chen, Weidong Zang, Austin M. Guo, John R. Falck, Raymond C Koehler, Jian Wang

Research output: Contribution to journalArticle

Abstract

20-HETE, an arachidonic acid metabolite synthesized by cytochrome P450 4A, plays an important role in acute brain damage from ischemic stroke or subarachnoid hemorrhage. We tested the hypothesis that 20-HETE inhibition has a protective effect after intracerebral hemorrhage (ICH) and then investigated its effect on angiogenesis. We exposed hippocampal slice cultures to hemoglobin and induced ICH in mouse brains by intrastriatal collagenase injection to investigate the protective effect of 20-HETE synthesis inhibitor N-hydroxy-N′-(4-n-butyl-2-methylphenyl)-formamidine (HET0016). Hemoglobin-induced neuronal death was assessed by propidium iodide after 18 h in vitro. Lesion volume, neurologic deficits, cell death, reactive oxygen species (ROS), neuroinflammation, and angiogenesis were evaluated at different time points after ICH. In cultured mouse hippocampal slices, HET0016 attenuated hemoglobin-induced neuronal death and decreased levels of proinflammatory cytokines and ROS. In vivo, HET0016 reduced brain lesion volume and neurologic deficits, and decreased neuronal death, ROS production, gelatinolytic activity, and the inflammatory response at three days after ICH. However, HET0016 did not inhibit angiogenesis, as levels of CD31, VEGF, and VEGFR2 were unchanged on day 28. We conclude that 20-HETE is involved in ICH-induced brain damage. Inhibition of 20-HETE synthesis may provide a viable means to mitigate ICH injury without inhibition of angiogenesis.

LanguageEnglish (US)
JournalJournal of Cerebral Blood Flow and Metabolism
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Cerebral Hemorrhage
Reactive Oxygen Species
Hemoglobins
Brain
Neurologic Manifestations
Propidium
Collagenases
Subarachnoid Hemorrhage
Arachidonic Acid
Cytochrome P-450 Enzyme System
Vascular Endothelial Growth Factor A
20-hydroxy-5,8,11,14-eicosatetraenoic acid
Cell Death
Stroke
Cytokines
Injections
Wounds and Injuries

Keywords

  • 20-Hydroxyeicosatetraenoic
  • angiogenesis
  • HET0016
  • inflammation
  • intracerebral hemorrhage

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

20-HETE synthesis inhibition promotes cerebral protection after intracerebral hemorrhage without inhibiting angiogenesis. / Han, Xiaoning; Zhao, Xiaochun; Lan, Xi; Li, Qian; Gao, Yufeng; Liu, Xi; Wan, Jieru; Yang, Zeng Jin; Chen, Xuemei; Zang, Weidong; Guo, Austin M.; Falck, John R.; Koehler, Raymond C; Wang, Jian.

In: Journal of Cerebral Blood Flow and Metabolism, 01.01.2018.

Research output: Contribution to journalArticle

Han, Xiaoning ; Zhao, Xiaochun ; Lan, Xi ; Li, Qian ; Gao, Yufeng ; Liu, Xi ; Wan, Jieru ; Yang, Zeng Jin ; Chen, Xuemei ; Zang, Weidong ; Guo, Austin M. ; Falck, John R. ; Koehler, Raymond C ; Wang, Jian. / 20-HETE synthesis inhibition promotes cerebral protection after intracerebral hemorrhage without inhibiting angiogenesis. In: Journal of Cerebral Blood Flow and Metabolism. 2018.
@article{1a39f02bb0b54913a7a5f091c2afa1fd,
title = "20-HETE synthesis inhibition promotes cerebral protection after intracerebral hemorrhage without inhibiting angiogenesis",
abstract = "20-HETE, an arachidonic acid metabolite synthesized by cytochrome P450 4A, plays an important role in acute brain damage from ischemic stroke or subarachnoid hemorrhage. We tested the hypothesis that 20-HETE inhibition has a protective effect after intracerebral hemorrhage (ICH) and then investigated its effect on angiogenesis. We exposed hippocampal slice cultures to hemoglobin and induced ICH in mouse brains by intrastriatal collagenase injection to investigate the protective effect of 20-HETE synthesis inhibitor N-hydroxy-N′-(4-n-butyl-2-methylphenyl)-formamidine (HET0016). Hemoglobin-induced neuronal death was assessed by propidium iodide after 18 h in vitro. Lesion volume, neurologic deficits, cell death, reactive oxygen species (ROS), neuroinflammation, and angiogenesis were evaluated at different time points after ICH. In cultured mouse hippocampal slices, HET0016 attenuated hemoglobin-induced neuronal death and decreased levels of proinflammatory cytokines and ROS. In vivo, HET0016 reduced brain lesion volume and neurologic deficits, and decreased neuronal death, ROS production, gelatinolytic activity, and the inflammatory response at three days after ICH. However, HET0016 did not inhibit angiogenesis, as levels of CD31, VEGF, and VEGFR2 were unchanged on day 28. We conclude that 20-HETE is involved in ICH-induced brain damage. Inhibition of 20-HETE synthesis may provide a viable means to mitigate ICH injury without inhibition of angiogenesis.",
keywords = "20-Hydroxyeicosatetraenoic, angiogenesis, HET0016, inflammation, intracerebral hemorrhage",
author = "Xiaoning Han and Xiaochun Zhao and Xi Lan and Qian Li and Yufeng Gao and Xi Liu and Jieru Wan and Yang, {Zeng Jin} and Xuemei Chen and Weidong Zang and Guo, {Austin M.} and Falck, {John R.} and Koehler, {Raymond C} and Jian Wang",
year = "2018",
month = "1",
day = "1",
doi = "10.1177/0271678X18762645",
language = "English (US)",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - 20-HETE synthesis inhibition promotes cerebral protection after intracerebral hemorrhage without inhibiting angiogenesis

AU - Han, Xiaoning

AU - Zhao, Xiaochun

AU - Lan, Xi

AU - Li, Qian

AU - Gao, Yufeng

AU - Liu, Xi

AU - Wan, Jieru

AU - Yang, Zeng Jin

AU - Chen, Xuemei

AU - Zang, Weidong

AU - Guo, Austin M.

AU - Falck, John R.

AU - Koehler, Raymond C

AU - Wang, Jian

PY - 2018/1/1

Y1 - 2018/1/1

N2 - 20-HETE, an arachidonic acid metabolite synthesized by cytochrome P450 4A, plays an important role in acute brain damage from ischemic stroke or subarachnoid hemorrhage. We tested the hypothesis that 20-HETE inhibition has a protective effect after intracerebral hemorrhage (ICH) and then investigated its effect on angiogenesis. We exposed hippocampal slice cultures to hemoglobin and induced ICH in mouse brains by intrastriatal collagenase injection to investigate the protective effect of 20-HETE synthesis inhibitor N-hydroxy-N′-(4-n-butyl-2-methylphenyl)-formamidine (HET0016). Hemoglobin-induced neuronal death was assessed by propidium iodide after 18 h in vitro. Lesion volume, neurologic deficits, cell death, reactive oxygen species (ROS), neuroinflammation, and angiogenesis were evaluated at different time points after ICH. In cultured mouse hippocampal slices, HET0016 attenuated hemoglobin-induced neuronal death and decreased levels of proinflammatory cytokines and ROS. In vivo, HET0016 reduced brain lesion volume and neurologic deficits, and decreased neuronal death, ROS production, gelatinolytic activity, and the inflammatory response at three days after ICH. However, HET0016 did not inhibit angiogenesis, as levels of CD31, VEGF, and VEGFR2 were unchanged on day 28. We conclude that 20-HETE is involved in ICH-induced brain damage. Inhibition of 20-HETE synthesis may provide a viable means to mitigate ICH injury without inhibition of angiogenesis.

AB - 20-HETE, an arachidonic acid metabolite synthesized by cytochrome P450 4A, plays an important role in acute brain damage from ischemic stroke or subarachnoid hemorrhage. We tested the hypothesis that 20-HETE inhibition has a protective effect after intracerebral hemorrhage (ICH) and then investigated its effect on angiogenesis. We exposed hippocampal slice cultures to hemoglobin and induced ICH in mouse brains by intrastriatal collagenase injection to investigate the protective effect of 20-HETE synthesis inhibitor N-hydroxy-N′-(4-n-butyl-2-methylphenyl)-formamidine (HET0016). Hemoglobin-induced neuronal death was assessed by propidium iodide after 18 h in vitro. Lesion volume, neurologic deficits, cell death, reactive oxygen species (ROS), neuroinflammation, and angiogenesis were evaluated at different time points after ICH. In cultured mouse hippocampal slices, HET0016 attenuated hemoglobin-induced neuronal death and decreased levels of proinflammatory cytokines and ROS. In vivo, HET0016 reduced brain lesion volume and neurologic deficits, and decreased neuronal death, ROS production, gelatinolytic activity, and the inflammatory response at three days after ICH. However, HET0016 did not inhibit angiogenesis, as levels of CD31, VEGF, and VEGFR2 were unchanged on day 28. We conclude that 20-HETE is involved in ICH-induced brain damage. Inhibition of 20-HETE synthesis may provide a viable means to mitigate ICH injury without inhibition of angiogenesis.

KW - 20-Hydroxyeicosatetraenoic

KW - angiogenesis

KW - HET0016

KW - inflammation

KW - intracerebral hemorrhage

UR - http://www.scopus.com/inward/record.url?scp=85044370465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044370465&partnerID=8YFLogxK

U2 - 10.1177/0271678X18762645

DO - 10.1177/0271678X18762645

M3 - Article

JO - Journal of Cerebral Blood Flow and Metabolism

T2 - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

ER -